Notice is hereby given that TD Lighthouse Capital Fund, L.P. (“TD Lighthouse”), 303 Detroit Street, Suite 301, Ann Arbor, Michigan 48104, a Federal Licensee under the Small Business Investment Act of 1958, as amended (“the Act”), in connection with the financing of a small concern, have sought an exemption under section 312 of the Act and section 107.730, Financings which Constitute Conflicts of Interest, of the Small Business Administration (“SBA”) rules and regulations (13 CFR 107.730 (2000)). TD Lighthouse proposes to provide equity financing to Quorex Pharmaceuticals, Inc. (“Quorex”), 2075 Corte Del Nogal, Suite J, Carlsbad, California 92009. The financing is contemplated for product development and working capital.
The financing is brought within the purview of Section 107.730(a)(1) of the Regulations because TD Origen Capital Fund, L.P. and TD Javelin Capital Fund II, L.P., Associates of TD Lighthouse, currently and collectively own greater than 10 percent of Quorex, and therefore Quorex is considered an Associate of TD Lighthouse as defined in section 107.50 of the regulations.
Notice is hereby given that any interested person may submit written comments on the transaction to the Associate Administrator for Investment, U.S. Small Business Administration, 409 Third Street, SW., Washington, DC 20416.Start Signature
Dated: March 19, 2001.
Acting Associate Administrator for Investment.
[FR Doc. 01-7488 Filed 3-26-01; 8:45 am]
BILLING CODE 8025-01-U